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1. Introduction 
Postprandial hyperglycemia is now established as an independent risk factor for the 
development of at least macro vascular complications in diabetes mellitus (1), as it is a 
widely accepted experience that it is more difficult to normalize postprandial blood glucose 
than the fasting concentrations. Furthermore, it is well known that impaired glucose 
tolerance (IGT) is related to increased cardiovascular morbidity and mortality (2) and that 
postprandial hyperglycemia plays a central role in progression from IGT to type 2 diabetes 
(3). It is possible to delay the appearance of type 2 diabetes and cardiovascular diseases in 
IGT patients by good glycemic control (4-8). The glycemic load as well as peak 
concentrations of glucose in the blood depend on many factors including gastric emptying, 
the nature of ingested food, intraluminal glucose concentration, and enzymatic activity in 
the brush border. On top of this several gut hormones play a role as well as the ability of the 
liver to reduce endogenous glucose production, being a special problem in patients with 
type 2 diabetes. This phenomenon increases the importance of reducing postprandial 
glucose uptake in type 2 diabetics. In addition, it seems possible to modify the insulin 
secretion after meals by addition of arabinose to the ingested sucrose (9). Sucrose contains 
equal amounts of glucose and fructose molecules. The absorption and metabolism of the 
two molecules is different. The absorbed glucose is utilized in an insulin dependent manner 
primarily in the peripheral tissues. Fructose is utilized in the liver in the glycolytic pathway 
with products like glucose, glycogen, lactate and pyruvate. Fructose is more lipogenic than 
glucose, an effect that might contribute to the development of cardiovascular diseases 
(CVD), insulin resistance and type 2 diabetes (10). Fructose does not stimulate insulin 
secretion as glucose why a modest intake of fructose is recomended in diabetes and heart 
patients due to the lipogenicity (10;11). Recently, a metaanalysis stated that fructose intake 
at a level of ≤ 36g/d, which is equivalent to daily intake of fruit, could have beneficial effects 
by decreasing endogenous glucose production and increasing glycogen synthesis, and 
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thereby improve glycaemic control. This benefit is seen without the adverse cardiometabolic 
effects reported when fructose is ingested in high doses or as excess energy (12).  
2. Disaccharidase activity in vitro 
The digestive enzymes, α-amylase and α-glucosidase are the key enzymes responsible for 
the digestion of carbohydrates to glucose. In search for modulators and/or inhibitors of 
disaccharidases various in vitro models for determination have been described in the 
literature. These represent quick and cheap screening procedures and include among others 
intestinal mucosa homogenates (13;14), intestinal brush border preparations (15) from 
different experimental animals, and homogenates of human intestinal cell line Caco-2 (9). 
The Caco-2 cells were originally derived from a human colon adenocarcinoma. In culture 
they proliferate and differentiate to cells resembling mature jejunocytes with high levels of 
brush-border enzyme activity including alkaline phosphatase, amino-peptidase, and 
sucrase-isomaltase (16). Although the Caco-2 cells are derived from colonic cells they 
represent human tissue and are thereby superior to animal tissue in relation to human 
studies. For kinetic studies on disaccharidase activity an in vitro model with homogenates of 
Caco-2 cells was established. Caco-2 cells from passage number 38 and 39 were seeded onto 
polycarbonate membranes (Fisher Scientific, Transwell®membrane, 75mm) and cultured at 
37°C and 5/95% CO2/air. At day 20-22, when the transepithelial electrical resistance (TEER) 
has reached a steady state level of 3-400 Ω*cm2, the Caco-2 cells were rinsed with phosphate 
buffered saline, scraped off the membranes, and homogenized by sonication. Homogenates  
 
 
Figure 1. Michaelis-Menten curves for the substrate (sucrose) concentrations 0 – 280 mM  with and 
without L-arabinose as inhibitor of sucrase (0.0mM (x), 0.84mM (□), 1.4mM (∆) and 2.8mM (○)). Data are 
mean±SEM (n=6). S is the substrate concentration and V is the velocity of the reaction. (Reproduced 
from Krog-Mikkelsen et al (2) with permission).  
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corresponding to 2.2 mg protein/mL and disaccharide solutions at final concentrations of 7, 
14, 28, 140, and 280 mM in 0.1 M maleate buffer, pH=6.0 were used. The amount of glucose 
released by the enzymatic reaction was linear with time up to 60 min, so a 30 min reaction time 
was used and glucose measured with a Cobas Mira Plus Spectrophotometer (Roche Diagnostic 
Systems, F Hoffmann-La Roche, Basel, Switzerland). Pentoses like L-arabinose and D-xylose 
were used as inhibitors at final concentrations of 0.84, 1.4, and 2.8 mM as exemplified with 
Michaelis-Menten curves for L-arabinose in fig 1 and Lineweaver-Burk plots in fig 2 (9). 
 
 
 
 
 
 
 
 
 
Figure 2. Lineweaver-Burk plots with and without L-arabinose as inhibitor of sucrase (0.0mM (x), 
0.84mM (□), 1.4mM (∆) and 2.8mM (○)). Data are mean±SEM (n=6). (Reproduced from Krog-Mikkelsen 
et al (2) with permission.) 
Reaction velocity (v) plotted against substrate concentration (s) revealed classical Michaelis-
Menten kinetics and demonstrated significant inhibition by increasing amounts of L-
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arabinose (fig 1) Lineweaver-Burke analysis (fig 2) indicated uncompetitive inhibition since 
Vmax decreased from 19.8 over 14.7 and 14.1 to 12.2 nmol/(min*mg protein), and Km 
decreased from 9.8 over 7.3 and 6.1 to 5.3 mmol/L when the inhibitor concentrations 
increased from zero over 0.84 and 1.4 to 2.8 mM L-arabinose (data not shown). Thus, 
addition of 0.84, 1.4, and 2.8 mM L-arabinose resulted in 25, 29 and 38% inhibition of the 
sucrase activity, respectively at Vmax. The apparent Ki was calculated to 2.8±0.3 mM 
(mean±SEM, n=3) from the Lineweaver-Burke plots (2). 
Similar results were obtained with sucrose as substrate and D-xylose as inhibitor, and with 
maltose as substrate and L-arabinose as inhibitor (data not shown). 
The validity of the in vitro model was confirmed in a human intervention study with 15 
healthy volunteers in a randomized double-blinded cross-over study. Sucrose beverages (75 
g in 300 mL) supplemented with 0, 1, 2, or 3 g (0, 1.3, 2.7 and 4 w/w%, respectively) L-
arabinose were tested (2). Blood was collected fasting and for 3-h postprandial with 15 
minute intervals, and plasma glucose and serum insulin measured (fig 3 and 4). 
 
 
 
 
 
Figure 3. Plasma glucose  in 15 normal male subjects after intake of sucrose drinks supplemented with 
0 (x), 1(□), 2 (∆), or 3 (○) grams of L-arabinose. Data are mean (± SEM). iAUC = incremental area under 
the curve. Statistical differences Peak, P=0.001. Time to peak, P=0.133. iAUC, P=0.245. (Reproduced from 
Krog-Mikkelsen et al (9) with permission.) 
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The present in vivo results in man strongly indicate that the Caco-2 cell model is useful in 
screening procedures in search for compounds which may lower the glycemic and insulimic 
responses in man. Importantly, because the Caco-2 cell line is of human origin, the results 
are more relevant for human physiology than studies with experimental animals. 
 
 
 
 
 
 
 
Figure 4. Serum insulin  in 15 normal male subjects after intake of sucrose drinks supplemented with 0 
(x), 1 (□), 2 (∆), or 3 (○) grams of L-arabinose. Data are mean (± SEM). Statistical differences Peak, 
P<0.0001. Time to peak, P=0.002. iAUC, P=0.017. (Reproduced from Krog-Mikkelsen et al (9) with 
permission.) 
3. The inhibition of the uptake of maltose and sucrose by food 
components 
In addition to the pentoses L-arabinose and D-xylose growing evidence indicates that 
various dietary polyphenols may influence carbohydrate metabolism. Several efforts are 
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made to identify new possible α-glucosidase inhibitors and interest in replacement of 
synthetic foods by natural ones has fostered research on vegetable sources and screening of 
raw materials to identify these α-glucosidase inhibitors (17-20). Polyphenols are abundant 
micronutrients in our diet, found in plants foods like fruits, vegetables, tea, coffee, red wine, 
and cacao. Studies with polyphenolic compounds, polyphenolic extracts of foods including 
berries, vegetables and colored grains such as black rice, green and black tea, and red wine 
have been shown to inhibit α-glucosidase activities and there by suppress the elevation of 
blood glucose concentrations when tested in especially small rodents (18). Additionally, 
different cell lines like Caco 2 cells mentioned above have been used in vitro. The inhibitory 
polyphenols includes flavonoids, phenolic acids, tannins (18). For example gallic acid and 
tannic acid have showed to be potential inhibitors of sucrase and other brush border 
enzymes in mice and rat (15;21;22). Extracts of acerola fruit have been studied and shows 
reduced plasma glucose level after oral administration of maltose or sucrose in mice, 
indicating inhibition of α-glucosidase effects on both sucrase and maltase in mice intestines 
(23-25). A hot water extract of leaves of Nerium Indicum, a bush from Pakistan, was found to 
reduce the rise in postprandial blood glucose when maltose and sucrose was given orally in 
rats. It was found that the extract inhibited α-glycosidase, suggesting the isolated polyphenols 
from the leaves extract, chlorogenic acid, to be the inhibitor of maltase and sucrose (26).  
4. Sugar beets 
The nutritional value of sucrose is to provide calories; nevertheless some studies have found 
that in the process of refining sugar from sugar beets and sugar cane some of the  by 
products like pulp and molasses  are important sources of bioactive compounds 
(polyphenols and pentoses). A study with sugar beet pulp revealed that the pulp contained 
polyphenolic compounds and had antioxidant properties (27;28). The same has been shown 
in studies with sugar cane products (29). The sugar beet molasses contains a variety of 
different phenolic acids mostly vanillic acid, syringic acid, p-coumaric acid, gallic acid, 
protocatechuic acid and ferulic acid the most abundant. 
For kinetic studies of sucrase activity, we used the aforementioned assay (2). As inhibitors 
two different polyphenol-rich fractions from chromatographic separation of molasses from 
sugar beets and pure ferulic acid were used. Results from the kinetic studies of EDC 
molasses, fraction III-2 molasses and pure ferulic acid (obtained from Nordic Sugar 
Denmark) are represented in figure 5-7. 
There were no inhibitory effects of EDC molasses or fraction III-2. Ferulic acid showed a 
week inhibition of 1.9 % for the concentration of 1 mM (Unpublished data). The variability 
of polyphenol content in foods is pronounced and in most cases, foods contain complex 
mixtures of polyphenols. The content is influenced by numerous factors such as variety, 
production practices at a particular processing plant, environmental factors and by storage 
variables. Even though, molasses contain a variety of different phenolic acids and pure 
ferulic acid inhibition of sucrose activity was weak at a relatively low concentration. This 
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indicates that there are still much to learn about the potential bioactivities and the 
bioavailabilities of polyphenolic compounds (30).  
 
Figure 5. Michaelis-Menten curves for the substrate (sucrose) concentrations 0 – 280 mM with and 
without fraction III-2 molasses as inhibitor of sucrose (n=4). [sucrose (◊)  Fraktion III-2 molasses (□)] 
 
 
Figure 6. Michaelis-Menten curves for the substrate (sucrose) concentrations 0 – 280 mM with and 
without 3 % EDC molasses as inhibitor of sucrose (n=4). Sucrose placebo represents the amount of 
sucrose in the EDC molasses.[sucrose (◊) 3% EDC molasses (□), Sucrose placebo (∆)] 
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Figure 7. Michaelis-Menten curves for the substrate (sucrose) concentrations 0 – 280 mM with and 
without 1mM ferulic acid as inhibitor of sucrase and 5,6 mM arabinose as inhibitor of sucrase. [sucrose 
(◊) 1 mM ferulic acid  (□), 5,6 mM arabinose (∆)]  
5. Intraluminal factors related to uptake of glucose  
It has been known for many years that dietary fibers reduce postprandial glucose 
concentrations in the blood, insulin response and delay gastric emptying. These effects have 
been established for a variety of fibers, but most markedly for soluble fibers. The character 
of chemical binding to the fibers are not well elucidated, neither the questions of existing 
physical binding mechanisms. The different processing methods of carbohydrates such as 
parboiling have verified effects on the glycemic response.  
One could ask whether the fiber-effects are due to the fibers, or can be explained by 
compensatory effects on the diet. That means if intake of fibers in the relevant amounts 
decreases appetite for fat and short chain carbohydrates, and thereby induces early satiety 
or changes food preferences towards other kinds of nutrients. These questions have only 
been addressed in very few publications and deserve to be discussed further. It has been 
very difficult to show that changes by fibers on appetite and food intake last more than 
around three weeks. This could be due to adaptation both to the direct effect of fibers, but 
also to adaption to the secondary effects such as food composition. 
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An additional question is the significance of formation of resistant starch during the 
preparation and production of food items.  
During the 1980`s it was well documented that dietary fibers have beneficial effects on blood 
glucose levels, the postprandial values in particular. The mechanisms, however, were not 
clear, and chemical bindings of glucose to elements in the fibers were hypothesized. Such 
bindings have never been convincingly proven, and at an early point these hypothesis were 
questioned. A study  used pectin in the glucose solution and modulated gastric emptying 
with propantheline (31) which demonstrated  that pectin significantly reduced blood-
glucose, but propantheline had a more pronounced effect. In an additional investigation in 
the same paper they demonstrated that both gastric emptying and paracetamol absorption 
were slower after inclusion of gel fiber (guar gum and pectin), but the total absorption of the 
drug, reflected in urinary recovery, was not significantly reduced. These results indicated 
that gastric emptying could be the dominating factor in the delay of glucose absorption. 
Later a long list of authors has contributed. Lavin and Read (32) found no difference in 
gastric emptying time when comparing fluent meal of  30 % glucose with or without guar 
gum, and speculated in an unknown mucosal receptor mechanism to explain the  effects on 
postprandial blood glucose and insulin concentrations as well as satiety. In contradiction 
Horowitz et al (33) found convincing correlations between gastric emptying and peak 
plasma glucose as well as the total amount of glucose absorbed using a scintigraphic 
technique, but with almost twice the concentration of glucose in the fluent meal and a 40 % 
larger volume compared to Lavin and Read (32). Horowitz et al (33) calculated that gastric 
emptying accounts for about 34 % of the variance in postprandial peak plasma glucose. The 
difference between these results could be explained by the techniques used, but also by the 
concentrations of glucose in the test meals. A study investigated the rehydration ability of 2 
and 10 % glucose-electrolyte solutions with osmolality of 189 and 654 mOsm/kg, 
respectively. Gastric volumes were determined via gastric aspiration at 15 min intervals. 
They showed that the reduced overall rate of fluid uptake following ingestion of the 10 % 
glucose solution was due largely to a relatively slow rate of gastric emptying (34). Hence the 
influence of gastric emptying on glucose uptake may only be relevant for solutions with 
very high concentrations of glucose, which is not relevant in relation to the human diet 
neither in normal persons nor in diabetic patients. This is in accordance with the hypothesis, 
that gastric content is only allowed access to the duodenum when iso-osmotic. Part of the 
delay in gastric emptying may well to allow a dilution with secreted water and sodium. 
All these results indicate that gastric emptying is probably the dominating factor, but not the 
only one. Blackburn et al (35) had the same results as others concerning the lowering of 
blood glucose and insulin, but there was no correlation between the changes in the 
individual blood glucose responses and changes in gastric emptying rates induced by guar. 
By a steady-state perfusion technique, glucose absorption was found to be significantly 
reduced during perfusion of the jejunum with solutions containing guar. They estimated the 
thickness of unstirred layer in addition, and concluded that guar improves glucose tolerance 
predominantly by reducing glucose absorption in the small intestine. These were very 
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elegant experiments, but has not been reproduced. However, another important influence 
on glucose uptake may be the rate of perfusion of the small intestine which can be 
modulated both by hormonal effects and meal composition (36).  
After glucose meals it seems like gastric emptying is a dominant intraluminal factor for 
glucose absorption. However, glucose is rarely ingested as glucose, and production of 
glucose in the stomach due to acid hydrolysis is not a predominant mechanism of glucose 
production. For these reasons it would be valuable to look at starch and sucrose as well. 
the hypothesis was investigated In another study with focus on particle size and structural 
features of the food. An extract from barley was used to modify the granules and the 
particle size, and found a decrease in the in-vitro starch digestion and accordingly release of 
glucose (37). Also starch-entrapped microspheres have been used with similar beneficial 
effects on the postprandial blood glucose response for different starch fractions (38). In 
addition it would be relevant to investigate the effects on brush border sucrose activity 
related to the different forms of glucose suppliers. 
In animal studies promising results are emerging. Kett et al (39) found that starch 
gelatinized with α-casein resulted in lower postprandial glucose uptake than starch 
gelatinized with β-casein. In rats a study found indications of an effect of addition of 
resistant starch to bread, but different effects for maize and wheat based bread (40). 
Besides from the more or less well described factors mentioned above, we see an 
emerging and probably very important field of  intestinal sensing of nutrients, recently 
reviewed by Tolhurst et al (41). Of special interest in the glucose aspect are the 
documented effects of psyllium fibers in the diet prolonging pancreatic polypeptide 
(PYY) secretion and suppressing postprandial glucagon-like peptide-1(GLP-1) 
concentration (42). 
6. Conclusions 
All together, these findings imply that there must be many possible ways of modifying food 
components to reduce the postprandial glucose levels in the blood. These modifications can 
be made both by induction of physical changes in the carbohydrates (gelatinization), 
additives and addition of food components already existing in nature. Arabinose is present 
in considerable amounts in the sugar beet along with sucrose, but the components are 
separated during the manufacturing process. Modifications of food components generally 
cost money, so it will partly be the consciousness of the consumers that will determine 
whether such products have a future on the market.  
The simplest way of getting an effect is still to increase the amount of dietary fibers in the 
diet, and hypothetically the largest effects would result from a change in eating habits in the 
total population. The results presented are from normal volunteers, and the same effects can 
be measured in diabetics, whereas results are lacking from persons/patients with insulin 
resistance but not yet diabetic. 
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